Innovative Medical Technology

Neurotron, Incorporated

   Innovative Medical Technology

                 Established 1981

Neurometer® End-Organ vs Direct Nerve Stimulation Publications

 Patient Care


 Press Releases






 Clinical Apps







  1. Porcheron, A., Mauger, E., Guinot, C., Tschachler, E., Morizot, F. Quantitative sensory methods: investigation of skin sensations in response to a chemical stress. Joint World Congress of International Society for Biophysics and Imaging of the Skin (ISBS) and International Society for Digital Imaging of the Skin (ISDIS). Poster 61, 2008.
  2. Lötsch J, Angst MS. The mu-opioid agonist remifentanil attenuates hyperalgesia evoked by blunt and punctuated stimuli with different potency: a pharmacological evaluation of the freeze lesion in humans. Pain Vol 102:151 - 161, 2003.
  3. Tegeder I, Meier S, Burian M, Schmidt H, Geisslinger G, and Lötsch J. Peripheral opioid analgesia in experimental human pain models. Brain, Vol 126(5), 1092-102, 2003.
  4. Gustorff, B., Hoerauf, K.H., Lierz, P., Kress, H.G. Comparison of different quantitative sensory testing methods during remifentanil infusion in volunteers. British Journal of Anaesthesia. Volume 91(2):203-8, 2003.
top of page      Previous page     Home


The entire contents of this web site are Copyright 1996-2010, Neurotron, Incorporated

Est. 1981, Baltimore, MD, USA.  All rights reserved, worldwide

rev 12/19/09